Clinical Trial Update: Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease [EARLY_Phase 1]

View source ↗

Summary

EARLY_PHASE1 Mayo Clinic trial evaluating sequences or combinations of dasatinib, quercetin, fisetin and/or temozolomide for previously treated glioma with resi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• DASATINIB (Dasatinib)
• Fisetin (fisetin)
• Quercetin (quercetin)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Glioma | EARLY_Phase 1 | Status: RECRUITING